Clinical Trial Update: Oral Acetyl-L-Carnitine Therapy Reduces Fatigue In Hepatic Encephalopathy [NA]

View source ↗

Summary

A completed clinical trial indicates that oral acetyl-L-carnitine may reduce fatigue in hepatic encephalopathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Encephalopathy

Drugs mentioned

• Acetyl-L-carnitine (N-acetyl-L-carnitine)

Snippet

Sponsor: University of Catania | Conditions: Hepatic Encephalopathy | NA | Status: COMPLETED